Home β€Ί Stock analysis β€Ί AFJKR

Aimei Health Technology (AFJKR) Stock: Why It's Up Today

Updated Oct 19, 2026, 12:05 PM ET Β· intraday price

What changed since yesterday

AFJKR jumps 5.1% to $0.09 on 35.0x normal volume. Trading at $0.09 (intraday, 12:05 PM ET), +5.06% vs the prior close of $0.08. Day range $0.09–$0.09, opened at $0.09.

Price (intraday)$0.09+5.06%
Day range0.09–0.09
Open0.09
Volume420
52-week range0.08–0.09
Avg volume (20d)216

AFJKR daily analysis β€” what happened

A plain-English, data-only note for every US trading day (today's note updates every 2 hours while the market is open). Newest first; older days stay archived below.

Oct 19, 2026 β€” AFJKR jumps 5.1% to $0.09 on 35.0x normal volume

AFJKR bull case vs bear case (from the data)

Bull case
  • Latest fiscal-year net income: profit of $1.06M.
  • Share count down 48.3% in a year (buybacks).
Bear case
  • High volatility: average daily move of 5.1% over 20 sessions.
  • Thin trading (under $2M a day on average) can mean wide bid/ask spreads.

AFJKR latest news & SEC filings

Every SEC filing by or about AFJKR in the last 120 days, explained in plain English. Updated daily, with a same-day refresh for new filings.

Oct 9, 2026 Β· Form PRE 14A β€” Preliminary proxy statement

Preliminary proxy statement

Source: SEC EDGAR filing 0001493152-26-046430

Oct 5, 2026 Β· Form 8-K β€” Major event / current report

Current report β€” a filing companies must make within 4 business days of a major event

Source: SEC EDGAR filing 0001493152-26-045745

Sep 3, 2026 Β· Form 8-K β€” Major event / current report

Current report β€” a filing companies must make within 4 business days of a major event

Source: SEC EDGAR filing 0001493152-26-041316

Aug 25, 2026 Β· Form 8-K β€” Major event / current report

Current report β€” a filing companies must make within 4 business days of a major event

Source: SEC EDGAR filing 0001493152-26-040044

Aug 13, 2026 Β· Form 10-Q β€” Quarterly report

Quarterly report (unaudited financial statements for the quarter)

Quarter ended Jun 30, 2026:

Source: SEC EDGAR filing 0001493152-26-037588

Aug 10, 2026 Β· Form SCHEDULE 13G/A β€” Update to a passive 5%+ stake (13G)

Update to a passive 5%+ stake (13G)

Filed by an outside investor (not the company). It reports a holding of more than 5% of a share class; percentage and holder name are in the filing.

Source: SEC EDGAR filing 0001604488-26-000081

Aug 6, 2026 Β· Form 8-K β€” Major event / current report

Current report β€” a filing companies must make within 4 business days of a major event

Source: SEC EDGAR filing 0001493152-26-036336

Aug 5, 2026 Β· Form SCHEDULE 13G/A β€” Update to a passive 5%+ stake (13G)

Update to a passive 5%+ stake (13G)

Filed by an outside investor (not the company). It reports a holding of more than 5% of a share class; percentage and holder name are in the filing.

Source: SEC EDGAR filing 0001628280-26-053520

Jul 8, 2026 Β· Form 8-K β€” Major event / current report

Current report β€” a filing companies must make within 4 business days of a major event

Source: SEC EDGAR filing 0001493152-26-032541

Jul 6, 2026 Β· Form 8-K β€” Major event / current report

Current report β€” a filing companies must make within 4 business days of a major event

Source: SEC EDGAR filing 0001493152-26-032151

Jul 1, 2026 Β· Form 3 β€” New insider holdings

Initial insider ownership statement (Form 3) β€” a new director, officer or 10% owner disclosed their holdings

Source: SEC EDGAR filing 0001493152-26-031457

Jun 29, 2026 Β· Form 8-K β€” Major event / current report

Current report β€” a filing companies must make within 4 business days of a major event

Source: SEC EDGAR filing 0001493152-26-031065

Things to know before you trade AFJKR

AFJKR market data (last 20 sessions)

DateOpenHighLowCloseVolume
Oct 19, 20260.090.090.090.09420
Oct 14, 20260.080.080.080.0812

About Aimei Health Technology

Aimei Health Technology (AFJKR) is listed on the Nasdaq and classified by the SEC under β€œBlank Checks”. Its business address is in NEW YORK, NY. Fiscal year ends December 31. SEC CIK 1979005.

AFJKR board of directors & executives

From SEC Form 3/4/5 insider filings made in the last 12 months (date = latest filing).

Directors

NameRoleLatest filing
Daniel Veikko PolviDirectorJul 1, 2026

Executive officers

NameTitleLatest filing
No Form 3/4/5 filings by this group in the last 12 months.

Recent insider buys & sales

DateInsiderTypeSharesPrice
No open-market insider buys or sales reported in the last 12 months.

AFJKR financials (annual, from XBRL filings)

Fiscal year endRevenueNet incomeDiluted EPSOperating cash flow
Dec 31, 2025β€”$1.06Mβ€”$-565.10K
Dec 31, 2024β€”$2.55Mβ€”$-672.29K

Latest balance sheet: total assets $12.53M, total liabilities $4.53M, cash $β€” (as of Jun 30, 2026).

AFJKR earnings / results-day log

DateFilingClose that day
No 8-K earnings releases in recent filings.

Related stocks Β· Blank Checks

Bold Eagle Acquisition (BEAG)Southport Acquisition Corp. II (PORT-UN)Live Oak Acquisition Corp. VI (LOVIU)Pine Tree Acquisition (PAXGU)Archimedes Tech SPAC Partners II (ATII)Frazier Life Sciences Acquisition Corp. II (FLSC)Innventure (INV)Bluerock Acquisition Corp. II (BRRKU)EQV Ventures Acquisition Corp. II (EVAC)Pyrophyte Acquisition Corp. II (PAII)

Popular today

Spdr S&P 500 Etf (SPY)Micron Technology (MU)Nvidia (NVDA)Meta Platforms (META)Sandisk (SNDK)Space Exploration Technologies (SPCX)Tesla (TSLA)Apple (AAPL)AMD (AMD)Microsoft (MSFT)Intel (INTC)Amazon (AMZN)

More on AFJKR

Information only, not investment advice. BuyMeWhiskey is not a registered investment adviser or broker-dealer; nothing here is a recommendation to buy, sell or hold any security, and there are no price targets. Data comes from SEC EDGAR filings and public end-of-day market data and may be delayed or contain errors. Verify with the company's filings before making decisions. Prices: intraday data as of Oct 19, 2026, 12:05 PM ET. Filings: SEC EDGAR. Refreshed every 2 hours during US market hours.